Skip to Main Content

Print | Bookmark | Email | Font Size: + |

September 28, 2023

Attention: CGS J15 Local Coverage Determination (LCD) L36690/A56696

Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers

L36690/A56696 Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers will not become effective on 10/01/2023. This was to replace the existing policy (also L36690) which will remain in effect.

A new Proposed LCD will be published for comment and presented at an Open Meeting in the near future.

spacer

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved